Analyzing more than one cellular biomarker (multiplexing) in a single sample is advantageous for a number of reasons. Multiplexing allows researchers to save money and time, while conserving critical samples. In addition, understanding the relationship between cell biomarkers can provide a more complete picture of cell health, leading to improved predictive models for drug discovery. Understanding biomarker relationships can also minimize ambiguity in the data set and validate if a treatment effect is real or an artifact of the system. To avoid repeat experiments and extract the most physiologically relevant data from multiplex cell-based assays, we discuss considerations around assay choices, cell type, cell culture, treatment parameters, detection and appropriate experimental controls.
Continue reading “Tips for Multiplex Cell-Based Assay Success”
Life is complicated. So is death. And when the cells in your multiwell plate die after compound treatment, it’s not enough to know that they died. You need to know how they died: apoptosis or necrosis? Or, have you really just reduced viability, rather than induced death? Is the cytotoxicity you see dose-dependent? If you look earlier during drug treatment of your cells, do you see markers of apoptosis? If you wait longer, do you observe necrosis? If you reduce the dosage of your test compound, is it still cytotoxic? 